Cernuumolide J
Product Specifications
CAS Number
2019163-02-9
Target
P38 MAPK, Apoptosis, STAT, JNK, JAK, ERK
Related Pathways
Stem Cells, Angiogenesis, Chromatin/Epigenetic, Tyrosine Kinase/Adaptors, MAPK, JAK/STAT signaling, Apoptosis
Bioactivity
Cernuumolide J (TMJ-105) functions as a JAK2/STAT3 inhibitor and exhibits potent activity against HEL leukemia cells by inhibiting their growth in both time-dependent and concentration-dependent manners, with an IC 50 value of 1.79 μM. This compound effectively induces G2/M phase arrest and apoptosis by downregulating the phosphorylation of JAK2, STAT3, and Erk, while simultaneously upregulating the phosphorylation of JNK and p38 MAPK. Cernuumolide J holds potential for research applications in anti-cancer therapy.
Smiles
O(C(C(C)C)=O)[C@@H]1[C@@]2([C@@]([C@H](OC(/C(=C\C)/C)=O)C(=O)[C@H](C)CCC[C@]1(C)O)(C(=C)C(=O)O2)[H])[H]
Molecular Formula
C24H34O8
Molecular Weight
450.52
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6387402 1.0 µg DNA
Shfm1 sgRNA CRISPR Lentivector (Rat) (Target 1)
Sign In for Pricing
View Details 
GTR15095301 1 Vial
Lentiviral human NRG3 shRNA (UAS) - Lentiviral human NRG3 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details